141 related articles for article (PubMed ID: 37908481)
1. Bartter Syndrome Type 1 Due to Novel
Kiuchi Z; Nozu K; Yan K; Jüppner H
JCEM Case Rep; 2023 Mar; 1(2):luad019. PubMed ID: 37908481
[TBL] [Abstract][Full Text] [Related]
2. [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].
Bando Y; Miyakoshi H; Nagaoka T; Ohsawa K; Kobayashi K
Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):676-87. PubMed ID: 1516722
[TBL] [Abstract][Full Text] [Related]
3. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1.
Adachi M; Asakura Y; Sato Y; Tajima T; Nakajima T; Yamamoto T; Fujieda K
Endocr J; 2007 Dec; 54(6):1003-7. PubMed ID: 17998760
[TBL] [Abstract][Full Text] [Related]
4. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review.
Gross I; Siedner-Weintraub Y; Simckes A; Gillis D
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):943-6. PubMed ID: 25741940
[TBL] [Abstract][Full Text] [Related]
5. Novel SLC12A1 mutations cause Bartter syndrome in two patients with different prognoses.
Yi S; Li M; Yang Q; Zhang X; Chen F; Qin Z; Yi S; Huang L; Wei H; Zhang Q; Luo J
Clin Chim Acta; 2022 Jun; 531():120-125. PubMed ID: 35358470
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the Na(+)-K(+)-2Cl(-) cotransporter NKCC2 in mice is associated with severe polyuria and a urea-selective concentrating defect without hyperreninemia.
Kemter E; Rathkolb B; Bankir L; Schrewe A; Hans W; Landbrecht C; Klaften M; Ivandic B; Fuchs H; Gailus-Durner V; Hrabé de Angelis M; Wolf E; Wanke R; Aigner B
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1405-15. PubMed ID: 20219826
[TBL] [Abstract][Full Text] [Related]
7. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients.
Wongsaengsak S; Vidmar AP; Addala A; Kamil ES; Sequeira P; Fass B; Pitukcheewanont P
Bone; 2017 Apr; 97():121-125. PubMed ID: 28095294
[TBL] [Abstract][Full Text] [Related]
8. Eight novel KCNJ1 variants and parathyroid hormone overaction or resistance in 5 probands with Bartter syndrome type 2.
Zuo J; Guo W; Wang S; Lang Y; Wang S; Shi X; Zhang R; Zhao X; Han Y; Shao L
Clin Chim Acta; 2020 Dec; 511():248-254. PubMed ID: 33058840
[TBL] [Abstract][Full Text] [Related]
9. Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome.
Brochard K; Boyer O; Blanchard A; Loirat C; Niaudet P; Macher MA; Deschenes G; Bensman A; Decramer S; Cochat P; Morin D; Broux F; Caillez M; Guyot C; Novo R; Jeunemaître X; Vargas-Poussou R
Nephrol Dial Transplant; 2009 May; 24(5):1455-64. PubMed ID: 19096086
[TBL] [Abstract][Full Text] [Related]
10. [Standard procedure and the diagnostic criteria for the Ellsworth-Howard test using human PTH-(1-34)].
Ogata E; Yamamoto M; Matsumoto T; Fujita T; Fukase M; Kinoshita Y; Furukawa Y; Sohn HE; Nakajima H; Yasuda T
Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):971-84. PubMed ID: 6096181
[TBL] [Abstract][Full Text] [Related]
11. Antenatal Bartter Syndrome Caused by a Novel Homozygous Mutation in
Acar FA; Işik G; Mutlu M; Kader Ş; Aslan Y; Kalyoncu M
Indian J Nephrol; 2019; 29(5):360-363. PubMed ID: 31571745
[TBL] [Abstract][Full Text] [Related]
12. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
Stögmann W
Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
[TBL] [Abstract][Full Text] [Related]
13. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes.
Shaer AJ
Am J Med Sci; 2001 Dec; 322(6):316-32. PubMed ID: 11780689
[TBL] [Abstract][Full Text] [Related]
14. Bartter Syndrome Type 1 Presenting as Nephrogenic Diabetes Insipidus.
Vergine G; Fabbri E; Pedini A; Tedeschi S; Borsa N
Case Rep Pediatr; 2018; 2018():9175271. PubMed ID: 29527380
[TBL] [Abstract][Full Text] [Related]
15. Late onset Bartter syndrome: Bartter syndrome type 2 presenting with isolated nephrocalcinosis and high parathyroid hormone levels mimicking primary hyperparathyroidism.
Yıldız G; Torun Bayram M; Çinleti T; Koç A; Soylu A; Kavukçu S
J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1298-1301. PubMed ID: 35952717
[TBL] [Abstract][Full Text] [Related]
16. Recurrent transient severe hypocalcaemia in two siblings with type 1 Bartter syndrome.
Kanda J; Kanda S; Hayashi Y; Nozu K; Ariji S; Shimoda M; Ono M; Kanda S; Yokoyama S; Takahashi K
Nephrology (Carlton); 2024 Mar; 29(3):164-167. PubMed ID: 38062639
[TBL] [Abstract][Full Text] [Related]
17. Association of Mutations in SLC12A1 Encoding the NKCC2 Cotransporter With Neonatal Primary Hyperparathyroidism.
Li D; Tian L; Hou C; Kim CE; Hakonarson H; Levine MA
J Clin Endocrinol Metab; 2016 May; 101(5):2196-200. PubMed ID: 26963954
[TBL] [Abstract][Full Text] [Related]
18. Clinical Findings and Genetic Analysis of Nine Mexican Families with Bartter Syndrome.
Hernández NEG; Pérez LIE; Aguilera D; Camargo-Muñiz MD; Espinosa CFC; Jaramillo MCR; Salvador C; González ZL; Hureaux M; Vargas-Poussou R
Arch Med Res; 2023 Sep; 54(6):102859. PubMed ID: 37516009
[TBL] [Abstract][Full Text] [Related]
19. [Functional characterization of SLC12A1 gene variants in 3 patients with Bartter syndrome type Ⅰ].
Sha YG; Wang CL; Du ZW; Zheng BX; Zhou W; Zhao F; Ding GX; Zhang A
Zhonghua Er Ke Za Zhi; 2022 Feb; 60(2):129-133. PubMed ID: 35090230
[No Abstract] [Full Text] [Related]
20. Tacrolimus ameliorates the phenotypes of type 4 Bartter syndrome model mice through activation of sodium-potassium-2 chloride cotransporter and sodium-chloride cotransporter.
Matsuura Y; Nomura N; Shoda W; Mori T; Isobe K; Susa K; Ando F; Sohara E; Rai T; Uchida S
Biochem Biophys Res Commun; 2019 Sep; 517(2):364-368. PubMed ID: 31362893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
